Shots:
Zomedica acquires Assisi’s assets & offers an additional drug-free solution to improve Zomedica pets’ ability for treating pain, inflammation, anxiety, or behavioral disorders. Assisi has developed a cutting-edge line of tPEMFTM devices for companion animals that offer a safe, drug-free alternative for treating pain, inflammation, anxiety, or behavioral issues
Clinical research has been done at Assisi on the use of tPEMF technology for treating pain, promoting healing, and reducing anxiety in companion animals
The acquisition will expand Zomedica’s product portfolio and continue to deliver solutions that enhance companion animal care while enhancing practice effectiveness and economic viability
Ref: Accesswire | Image: Assisi
